RAS(ON) inhibitors

· Revolution Medicines, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RAS(ON) inhibitors, covering 2026-03-09 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors [Phase 1, Phase 2]